ET Deep Dive: The DNA Fix
from The Morning Brief Hosted by The Economic Times
A revolution is underway in cancer diagnosis. A gene-based test called next-generation sequencing can identify precise mutations in a patient’s DNA, which can then be treated with targeted therapies instead of painful chemotherapy. For an 80-year-old woman with stage 4 lung cancer, it meant walking again. For a 24-year-old with breast cancer, it meant a normal life. But since NGS tests can cost up to Rs 4 lakh, a unique collaboration called LuNGS Alliance is making it free for lung cancer patients across India — offering a glimpse of how medical breakthroughs can be made accessible and affordable for all. Vikas Dandekar and Arijit Barman report. Anirban Chowdhury narrates for audio Listen in.
Embed this episode
No transcript yet.